Treatment of trauma with lithium to forestall the development of posttraumatic stress disorder by pharmacological induction of a mild transient amnesia

Medical Hypotheses

Volumn 80, Issue 6, 2013, Pages 711-715

  Wallace, James ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; LITHIUM;

AMNESIA; ARTICLE; CALCIUM CELL LEVEL; DISEASE SEVERITY; HUMAN; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; POSTTRAUMATIC STRESS DISORDER; SYMPTOM;

AMNESIA; HUMANS; LITHIUM; LONG-TERM POTENTIATION; MODELS, BIOLOGICAL; NEURONAL PLASTICITY; STRESS DISORDERS, POST-TRAUMATIC; WOUNDS AND INJURIES;

EID: 84877144440     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.02.017     Document Type: Article

References (53)

1. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005, 62(6):593-602.
2. Brewin C.R., Andrews B., Valentine J.D. Meta-analysis of risk factors for posttraumatic stress disorder in trauma-exposed adults. J Consult Clin Psychol 2000, 68(5):748-766.
3. Pitman R.K. Post-traumatic stress disorder, hormones, and memory. Biol Psychiatry 1989, 26(3):221-223.
4. Pitman R.K., Delahanty D.L. Conceptually driven pharmacologic approaches to acute trauma. CNS Spectr 2005, 10(2):99-106.
5. Phelps E.A. Human emotion and memory: interactions of the amygdala and hippocampal complex. Curr Opin Neurobiol 2004, 14(2):198-202.
6. Kandel E.R. The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB. Mol Brain 2012, 5:14.
7. Cajal S.R. La fine structure des centres nerveux. Proc R Soc Lond 1894, 55:444-468.
8. Konorski J. Conditioned reflexes and neuron organization 1948, Cambridge University Press, New York.
9. Hebb D.O. The organization of behavior: a neuropsychological theory 1949, Wiley, New York.
10. Scoville W.B., Milner B. Loss of recent memory after bilateral hippocampal lesions. J Neurol Neurosurg Psychiatry 1957, 20(1):11-21.
11. Squire L.R. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol Rev 1992, 99(2):195-231. [Erratum in: Psychol Rev 1992;99(3):582].
12. Bliss T.V., Lømo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 1973, 232(2):331-356.
13. Douglas R.M., Goddard G.V. Long-term potentiation of the perforant path-granule cell synapse in the rat hippocampus. Brain Res 1975, 86(2):205-215.
14. Malenka R.C., Bear M.F. LTP and LTD: an embarrassment of riches. Neuron 2004, 44(1):5-21.
15. Antonova I., Arancio O., Trillat A.C., et al. Rapid increase in clusters of presynaptic proteins at onset of long-lasting potentiation. Science 2001, 294(5546):1547-1550.
16. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361(6407):31-39.
17. Lynch G., Larson J., Kelso S., Barrionuevo G., Schottler F. Intracellular injections of EGTA block induction of hippocampal long-term potentiation. Nature 1983, 305(5936):719-721.
18. Malenka R.C., Kauer J.A., Zucker R.S., Nicoll R.A. Postsynaptic calcium is sufficient for potentiation of hippocampal synaptic transmission. Science 1988, 242(4875):81-84.
19. Henzi V., MacDermott A.B. Characteristics and function of Ca(2+) - and inositol 1,4,5-trisphosphate-releasable stores of Ca2+ in neurons. Neuroscience 1992, 46(2):251-273.
20. Berridge M.J. Inositol trisphosphate and calcium signalling. Nature 1993, 361(6410):315-325.
21. Berridge M.J. Neuronal calcium signaling. Neuron 1998, 21(1):13-26.
22. Streb H., Irvine R.F., Berridge M.J., Schulz I. Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature 1983, 306(5938):67-69.
23. Marzo A., Bai J., Otani S. Neuroplasticity regulation by noradrenaline in mammalian brain. Curr Neuropharmacol 2009, 7(4):286-295.
24. Davidson J.R. Pharmacologic treatment of acute and chronic stress following trauma: 2006. J Clin Psychiatry 2006, 67(Suppl. 2):34-39.
25. Jeffreys M., Capehart B., Friedman M.J. Pharmacotherapy for posttraumatic stress disorder: review with clinical applications. J Rehabil Res Dev 2012, 49(5):703-715.
26. Raskind M.A., Peskind E.R., Kanter E.D., et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry 2003, 160(2):371-373.
27. Taylor F.B., Martin P., Thompson C., et al. Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study. Biol Psychiatry 2008, 63(6):629-632.
28. Nilsson T., Zwiller J., Boynton A.L., Berggren P.O. Heparin inhibits IP3-induced Ca2+ release in permeabilized pancreatic beta-cells. FEBS Lett 1988, 229(1):211-214.
29. Vargas R., Cifuentes F., Morales M.A. Role of presynaptic and postsynaptic IP3-dependent intracellular calcium release in long-term potentiation in sympathetic ganglion of the rat. Synapse 2011, 65(5):441-448.
30. Pachet A.K., Wisniewski A.M. The effects of lithium on cognition: an updated review. Psychopharmacology (Berl) 2003, 170(3):225-234.
31. Wingo A.P., Wingo T.S., Harvey P.D., Baldessarini R.J. Effects of lithium on cognitive performance: a meta-analysis. J Clin Psychiatry 2009, 70(11):1588-1597.
32. Birch N.J. Letter: lithium and magnesium-dependent enzymes. Lancet 1974, 2(7886):965-966.
33. Frausto da Silva J.J., Williams R.J. Possible mechanism for the biological action of lithium. Nature 1976, 263(5574):237-239.
34. Amari L., Layden B., Rong Q., Geraldes C.F., Mota de Freitas D. Comparison of fluorescence, (31)P NMR, and (7)Li NMR spectroscopic methods for investigating Li(+)/Mg(2+) competition for biomolecules. Anal Biochem 1999, 272(1):1-7.
35. Pasquali L., Busceti C.L., Fulceri F., Paparelli A., Fornai F. Intracellular pathways underlying the effects of lithium. Behav Pharmacol 2010, 21(5-6):473-492.
36. Naccarato W.F., Ray R.E., Wells W.W. Biosynthesis of myo-inositol in rat mammary gland. Isolation and properties of the enzymes. Arch Biochem Biophys 1974, 164(1):194-201.
37. Hallcher L.M., Sherman W.R. The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J Biol Chem 1980, 255(22):10896-10901.
38. Berridge M.J., Downes C.P., Hanley M.R. Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem J 1982, 206(3):587-595.
39. Klein P.S., Melton D.A. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 1996, 93(16):8455-8459.
40. Stambolic V., Ruel L., Woodgett J.R. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 1996, 6(12):1664-1668.
41. Ryves W.J., Harwood A.J. Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem Biophys Res Commun 2001, 280(3):720-725.
42. Nonaka S., Hough C.J., Chuang D.M. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc Natl Acad Sci USA 1998, 95(5):2642-2647.
43. Reisberg B., Doody R., Stöffler A., Schmitt F., Ferris S., Möbius H.J. Memantine study group. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 2003, 348(14):1333-1341.
44. Morris R.G. Long-term potentiation and memory. Philos Trans R Soc Lond B Biol Sci 2003, 358(1432):643-647.
45. Allison J.H., Stewart M.A. Reduced brain inositol in lithium-treated rats. Nat New Biol 1971, 233(43):267-268.
46. Berridge M.J., Downes C.P., Hanley M.R. Neural and developmental actions of lithium: a unifying hypothesis. Cell 1989, 59(3):411-419.
47. Sarkar S., Floto R.A., Berger Z., et al. Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol 2005, 170(7):1101-1111.
48. Sourial-Bassillious N., Rydelius P.A., Aperia A., Aizman O. Glutamate-mediated calcium signaling: a potential target for lithium action. Neuroscience 2009, 161(4):1126-1134.
49. Kessing L.V., Forman J.L., Andersen P.K. Does lithium protect against dementia?. Bipolar Disord 2010, 12(1):87-94.
50. Squire L.R. Memory functions as affected by electroconvulsive therapy. Ann N Y Acad Sci 1986, 462:307-314.
51. Kragh J., Jørgensen M.B., Diemer N.H., Bolwig T.G. Long-term decrease in the hippocampal [3H] inositoltriphosphate binding following repeated electroshock in the rat. Biol Psychiatry 1995, 38(7):471-474.
52. Swartz C.M., Nelson A.I. Rational electroconvulsive therapy electrode placement. Psychiatry (Edgmont) 2005, 2(7):37-43.
53. Sackeim H.A., Prudic J., Nobler M.S., et al. Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimul 2008, 1(2):71-83.